Truist Financial
EXAS

Truist Financial’s Exact Sciences EXAS Stock Holding History

Truist Financial’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-11,091
Closed -$1.13M – 2839
2025
Q4 		$1.13M Sell
11,091
-8,837
-44% -$710K ﹤0.01% 1597
2025
Q3 		$1.09M Buy
19,928
+3,624
+22% +$181K ﹤0.01% 1625
2025
Q2 		$866K Buy
16,304
+2,582
+19% +$131K ﹤0.01% 1662
2025
Q1 		$594K Buy
13,722
+1,705
+14% +$86.3K ﹤0.01% 1779
2024
Q4 		$675K Sell
12,017
-1,905
-14% -$119K ﹤0.01% 1733
2024
Q3 		$948K Sell
13,922
-1,907
-12% -$108K ﹤0.01% 1550
2024
Q2 		$669K Sell
15,829
-1,892
-11% -$104K ﹤0.01% 1806
2024
Q1 		$1.22M Sell
17,721
-1,583
-8% -$100K ﹤0.01% 1516
2023
Q4 		$1.43M Buy
19,304
+908
+5% +$59.5K ﹤0.01% 1428
2023
Q3 		$1.25M Sell
18,396
-861
-4% -$73.1K ﹤0.01% 1466
2023
Q2 		$1.81M Buy
19,257
+710
+4% +$55.4K ﹤0.01% 1304
2023
Q1 		$1.26M Buy
18,547
+442
+2% +$28.4K ﹤0.01% 1448
2022
Q4 		$896K Sell
18,105
-356
-2% -$14.5K ﹤0.01% 1605
2022
Q3 		$600K Sell
18,461
-617
-3% -$25.4K ﹤0.01% 1730
2022
Q2 		$751K Sell
19,078
-1,413
-7% -$75.6K ﹤0.01% 1685
2022
Q1 		$1.43M Sell
20,491
-4,482
-18% -$328K ﹤0.01% 1447
2021
Q4 		$1.94M Sell
24,973
-3,959
-14% -$349K ﹤0.01% 1309
2021
Q3 		$2.76M Buy
28,932
+1,813
+7% +$191K ﹤0.01% 1123
2021
Q2 		$3.37M Buy
27,119
+963
+4% +$115K 0.01% 1043
2021
Q1 		$3.45M Buy
26,156
+9,327
+55% +$1.28M 0.01% 999
2020
Q4 		$2.23M Buy
16,829
+1,105
+7% +$134K ﹤0.01% 1126
2020
Q3 		$1.6M Buy
15,724
+11,101
+240% +$959K ﹤0.01% 1162
2020
Q2 		$402K Buy
4,623
+505
+12% +$40.3K ﹤0.01% 1748
2020
Q1 		$239K Sell
4,118
-7,429
-64% -$603K ﹤0.01% 2011
2019
Q4 		$1.07M Buy
+11,547
New +$1.02M ﹤0.01% 1407

Other funds holding EXAS

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
PWMAG
Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.46B AUM 22.77% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return
BC
Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

Truist Financial's EXAS Position: Q1 2026 in Review

Truist Financial sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 11,091 shares — an estimated $1.13M sold.

Truist Financial first reported a position in EXAS in Q4 2019 and held it in 25 quarters. The position peaked at $3.45M in Q1 2021. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • Truist Financial reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • Truist Financial sold 11,091 Exact Sciences shares in Q1 2026, an estimated $1.13M.
  • Truist Financial first reported a position in Exact Sciences in Q4 2019 and held it in 25 quarters.
  • Truist Financial's Exact Sciences position peaked at $3.45M in Q1 2021.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on Truist Financial's 13F filing for Q1 2026, filed 27 Apr 2026.